Repare Therapeutics
Biotech · Acquired
ATR kinase inhibitor (Camonsertib) and synthetic lethality platform for BRCA-mutant cancers
reparetx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 32
- 3 granted · 29 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3330 | ONCOSYNERGY, INC. | — | $27M |
| 3331 | SOLUBLE THERAPEUTICS, INC. | — | — |
| 3332 | SIEYAX, INC | — | — |
| 3333 | Repare Therapeutics | — | — |
| 3334 | HOUSEY PHARMACEUTICAL RESEARCH LAB | — | — |
| 3335 | Alpha-9 Oncology | — | — |
| 3336 | ABBRATECH INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Substituted 2-MORPHOLINOPYRIDINE Derivatives As Atr Kinase Inhibitorsgranted
- Methods Of Identifying Cancers Having A Biallelic Loss Of Function Mutationapplication
- Compounds, Pharmaceutical Compositions, And Methods Of Preparing Compounds And Of Their Usegranted
- Heteroarenes, Pharmaceutical Compositions Containing The Same, And Methods Of Using The Sameapplication
- Methods Of Using Atr Inhibitorsapplication
- Polo-like Kinase 4 (PLK4) Inhibitors, Pharmaceutical Compositions, Methods Of Preparation And Uses Thereofapplication
- Compounds, Pharmaceutical Compositions, And Methods Of Preparing Compounds And Of Their Use As Atr Kinase Inhibitorsapplication
- Compounds, Pharmaceutical Compositions, And Methods Of Preparing Compounds And Of Their Use As Atr Kinase Inhibitorsgranted
- Combination Treatment Of Cancersapplication
- Methods Of Treating Cancers Having A Biallelic Loss Of Function Or Gene Overexpression Mutationapplication
- Use Of Atr Inhibitors In Combination With Parp Inhibitorsapplication
- Crystalline Forms, Compositions Containing Same, And Methods Of Their Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.